Qube Research & Technologies (QRT)
NRC icon

Qube Research & Technologies (QRT)’s NRC Health Common Stock NRC Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio NRC Stock Details NRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-20,798
Closed -$266K – 3947
2025
Q3 		$266K Sell
20,798
-9,260
-31% -$139K ﹤0.01% 2882
2025
Q2 		$505K Sell
30,058
-30,563
-50% -$413K ﹤0.01% 2691
2025
Q1 		$776K Sell
60,621
-5,349
-8% -$85.8K ﹤0.01% 2364
2024
Q4 		$1.16M Sell
65,970
-3,540
-5% -$67.1K ﹤0.01% 2108
2024
Q3 		$1.59M Sell
69,510
-4,982
-7% -$113K ﹤0.01% 1857
2024
Q2 		$1.71M Buy
74,492
+39,329
+112% +$1.21M ﹤0.01% 1705
2024
Q1 		$1.39M Buy
35,163
+10,881
+45% +$430K ﹤0.01% 1952
2023
Q4 		$961K Buy
24,282
+23,279
+2,321% +$974K ﹤0.01% 1954
2023
Q3 		$44.5K Buy
+1,003
New +$43.8K ﹤0.01% 2903
2023
Q2 		– Sell
-5,964
Closed -$259K – 2802
2023
Q1 		$259K Buy
+5,964
New +$263K ﹤0.01% 1828
2022
Q2 		– Sell
-11,041
Closed -$438K – 2926
2022
Q1 		$438K Buy
11,041
+2,144
+24% +$83.9K ﹤0.01% 1596
2021
Q4 		$369K Buy
+8,897
New +$387K ﹤0.01% 1699

Other funds holding NRC

Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
QI
QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Qube Research & Technologies (QRT)'s NRC Position: Q4 2025 in Review

Qube Research & Technologies (QRT) sold out of NRC Health Common Stock (NRC) in Q4 2025, closing a stake of 20,798 shares — an estimated $266K sold.

Qube Research & Technologies (QRT) first reported a position in NRC in Q4 2021 and held it in 12 quarters. The position peaked at $1.71M in Q2 2024. 117 funds tracked by Wall St. Rank hold NRC as of Q4 2025.

  • Qube Research & Technologies (QRT) reported no remaining NRC Health Common Stock position as of Q4 2025 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 20,798 NRC Health Common Stock shares in Q4 2025, an estimated $266K.
  • Qube Research & Technologies (QRT) first reported a position in NRC Health Common Stock in Q4 2021 and held it in 12 quarters.
  • Qube Research & Technologies (QRT)'s NRC Health Common Stock position peaked at $1.71M in Q2 2024.
  • 117 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q4 2025.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2025, filed 17 Feb 2026.